CE: Current and Emerging Applications of Fecal Microbiota Transplantation

Area of Science:

• Gastroenterology and Microbiology

Background:

• Recurrent Clostridioides difficile infection (rCDI) causes severe gastrointestinal distress and can be exacerbated by antibiotic treatments.
• Antibiotics disrupt the gut microbiome, potentially leading to antimicrobial resistance and necessitating alternative therapies.
• Fecal microbiota transplantation (FMT) introduces a healthy donor microbiome to combat rCDI.

Purpose of the Study:

• To provide an overview of the FMT procedure for treating rCDI.
• To discuss the nursing management of patients undergoing FMT.
• To explore emerging applications of FMT beyond rCDI.

Main Methods:

• Review of current literature on FMT for rCDI.
• Discussion of the gastrointestinal microbiome's role in rCDI.
• Presentation of a case scenario illustrating FMT treatment.

Main Results:

• FMT leads to significant clinical improvement and enhanced quality of life for rCDI patients.
• The procedure strengthens the recipient's compromised gut microbiome.
• Emerging applications of FMT show promise for various conditions.

Conclusions:

• FMT is a highly effective treatment for rCDI, offering a viable alternative to antibiotics.
• Comprehensive nursing management is crucial for successful FMT outcomes.
• Further research into FMT's broader therapeutic potential is warranted.